Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Onconetix (ONCO) FCF Margin (2023 - 2025)

Historic FCF Margin for Onconetix (ONCO) over the last 3 years, with Q3 2025 value amounting to 1050.56%.

  • Onconetix's FCF Margin fell 7681800.0% to 1050.56% in Q3 2025 from the same period last year, while for Sep 2025 it was 614.97%, marking a year-over-year increase of 2420500.0%. This contributed to the annual value of 417.12% for FY2024, which is 332111900.0% up from last year.
  • According to the latest figures from Q3 2025, Onconetix's FCF Margin is 1050.56%, which was down 7681800.0% from 1324.0% recorded in Q2 2025.
  • Over the past 5 years, Onconetix's FCF Margin peaked at 3689.36% during Q2 2023, and registered a low of 1967.92% during Q1 2025.
  • Over the past 3 years, Onconetix's median FCF Margin value was 369.41% (recorded in 2024), while the average stood at 114.73%.
  • Per our database at Business Quant, Onconetix's FCF Margin crashed by -41458100bps in 2024 and then crashed by -7681800bps in 2025.
  • Onconetix's FCF Margin (Quarter) stood at 2287.08% in 2023, then crashed by -106bps to 130.02% in 2024, then crashed by -708bps to 1050.56% in 2025.
  • Its last three reported values are 1050.56% in Q3 2025, 1324.0% for Q2 2025, and 1967.92% during Q1 2025.